Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Explore value comparisons for travel points redemptions to make informed choices. Get the most out of your rewards.
22,567 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A weekend military action in the Middle East pushed Treasuries higher and lifted mortgage rates, complicating spring ...
February layoffs slowed to 48,307, down sharply from January and far below last year's level. Analysts warn volatilit...
A 2024 submarine cable incident revealed Bitcoin’s resilience as researchers map how topology and redundancy protect ...
Investors are weighing three very different tech names as AI upgrades drive Nvidia higher while Qualcomm faces a toug...
As markets bounce between frenzy and caution, investors are weighing two paths: a focused bet on seven mega-cap names...
The AI model Claude released a year-end forecast for XRP, Bitcoin and Ethereum, presenting base, bull and bear paths ...
A geopolitical clash has spilled into cyberspace, unleashing AI-augmented attacks on corporate networks. Fortune 500 ...
Global market shifts in 2026 make international exposure a potential anchor for retirement income and diversification...
Through the first three months of 2026, the stock market diverged: the S&P 500 fell, while smaller firms outperformed...
The Nasdaq down from high has created a disciplined buying moment for patient investors. This guide highlights five t...
In a markets backdrop marked by higher rates and sector stresses, SRET continues to pay monthly distributions, unders...